Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage

Oral Microbiology and Immunology

Volumn 21, Issue 6, 2006, Pages 360-365

  Alayan, J ^a   Ivanovski, S ^a   Gemmell, E ^a   Ford, P ^a   Hamlet, S ^a   Farah, C S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alveolar bone loss; Inducible nitric oxide synthase; Knockout mice; Porphyromonas gingivalis

Indexed keywords

CYTOKINE; INTERLEUKIN 2; NITRIC OXIDE SYNTHASE;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; ENZYME DEFICIENCY; IMMUNE RESPONSE; INFLAMMATORY DISEASE; MONOCYTE; MOUSE; MOUTH INFECTION; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; SKIN ABSCESS; TISSUE INJURY; WILD TYPE;

ABSCESS; ALVEOLAR BONE LOSS; ANIMALS; FEMALE; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; VIRULENCE FACTORS;

EID: 33750298321     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2006.00304.x     Document Type: Article

References (35)

1. Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC. CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999: 67: 2804-2809.
2. Batista A, Silva T, Chun J, Lara V. Nitric oxide synthesis and severity of human periodontal disease. Oral Dis 2002: 8: 254-260.
3. Bird PS, Gemmell E, Polak B, Paton RG, Sosroseno W, Seymour GJ. Protective immunity to Porphyromonas gingivalis infection in a murine model. J Periodontol 1995: 66: 351-362.
4. Blix I, Helgland K. LPS from Actinobacillus actinomycetemcomitans and production of nitric oxide in murine macrophages. Eur J Oral Sci 1998: 106: 576-581.
5. Bogdan C. Nitric oxide and the immune response. Nature 2001: 2: 907-916.
6. Brandi M, Hukkanen M, Umeda T et al. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci U S A 1995: 92: 2954-2958.
7. Buttery L, Aguirre IJ, Hukkanen M et al. Nitric oxide stimulates osteoblast replication and development. J Bone Miner Res 1999: 14: 1154.
8. Chae H, Park R, Chung H et al. Nitric oxide is a regulator of bone remodelling. J Pharm Pharmacol 1997: 49: 897-902.
9. Chiang T, Woo-Rasberry V, Cole F. Role of platelet endothelial form of nitric oxide synthase in collagen-platelet interaction: regulation by phosphorylation. Biochim Biophys Acta 2002: 1592: 169-174.
10. Cohen DW, Morris AL. Periodontal manifestation of cyclic neutropenia. J Periodontol 1961: 32: 159-168.
11. Dennison DK, Van Dyke TE. The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontol 2000 1997: 14: 54-78.
12. Gemmell E, Kjeldsen M, Yamazaki K, Nakajima T, Aldred M, Seymour GJ. Cytokine profiles of Porphyromonas gingivalis-reactive T-lymphocyte line and clones derived from P. gingivalis-infected subjects. Oral Dis 1995: 1: 139-146.
13. Gemmell E, Winning T, Bird PS, Seymour GJ. Cytokine profiles of lesional and splenic T-cells in Porphyromonas gingivalis infection in a murine model. J Periodontol 1998: 69: 1131-1138.
14. Gyurko R, Boustany G, Huang PL et al. Mice lacking inducible nitric oxide synthase demonstrated impaired killing of Porphyromonas gingivalis. Infect Immun 2003: 71: 4917-4924.
15. Gyurko R, Shoji H, Battaglino R et al. Inducible nitric oxide synthase mediates bone development and P. gingivalis-induced alveolar bone loss. Bone 2005: 36: 472-479.
16. Hamilton RE, Giansanti JS. The Chediak-Higashi syndrome. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 1974: 37: 754-761.
17. Huang FP, Niedbala W, Wei XQ et al. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 1998: 28: 4062-4070.
18. Kendall H, Haase HR, Li H, Xia Y, Bartold PM. Nitric oxide synthase type-2 is synthesized by human gingival tissue and cultured human gingival fibroblasts. J Periodontal Res 2000: 35: 194-200.
19. Laurent M, Lepoivre M, Tenu J. Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase. Biochem J 1996: 314: 109-113.
20. MacIntyre I, Zaidi M, Alam A et al. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci U S A 1991: 88: 2936-2940.
21. MacMicking JD, Nathan C, Hom G et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995: 81: 641-650.
22. Mclean A, Wei XQ, Huang FP, Al-Alem UAH, Chan WL, Liew FY. Mice lacking inducible nitric oxide synthase are now more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J Gen Virol 1998: 79: 825-830.
23. Moncada S, Higgs E. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 1991: 21: 361-374.
24. Ralston S, Ho L, Helfrich M, Grabowski P, Johnston P, Benjamin N. Nitric oxide: a cytokine induced regulator of bone resorption. J Bone Miner Res 1995: 10: 1040-1049.
25. Ralston S, Todd D, Helfrich M, Benjamin N, Grabowski P. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994: 135: 330-336.
26. Riancho J, Salas E, Zarrabeitia M et al. Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Miner Res 1995: 10: 439-446.
27. Schletter J, Heine H, Ulmer A, Rietschel E. Molecular mechanisms of endotoxin activity. Arch Microbiol 1995: 164: 383-389.
28. Socransky SS, Haffajee AD. The bacterial aetiology of destructive periodontal disease: current concepts. J Periodontol 1992: 63: 322-331.
29. Springer TA, Thompson WS, Miller LJ, Schmalstieg FC, Anderson D. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 1984: 160: 1901-1918.
30. Tatakis DN, Guglielmoni P. HLA-B27 transgenic rats are susceptible to accelerated alveolar bone loss. J Periodontol 2000: 71: 1395-1400.
31. Taylor EL, Megson IL, Haslett C, Rossi AG. Dissociation of DNA fragmentation from other hallmarks of apoptosis in nitric oxide-treated neutrophils: differences between individual nitric oxide donor drugs. Biochem Biophys Res Commun 2001: 289: 1229-1236.
32. van't Hof R, Ralston S. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J Bone Miner Res 1997: 12: 1797-1804.
33. van't Hof R, Ralston S. Nitric oxide and bone. Immunology 2001: 103: 255-261.
34. Wei XQ, Charles IG, Smith A. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995: 375: 408-411.
35. Xie QW, Cho J, Calaycay RA et al. Cloning and characterization if inducible nitric oxide synthase from mouse macrophages. Science 1992: 256: 225-228.